The following information has been compiled as a central resource for information on access to care and reimbursement issues for Alphas who require assistance to ensure access to FDA-approved augmentation therapy products in the United States.
Telephone: (866) 6-ALPHA-1 – (866) 625-7421
Preferred provider for: Takeda (Aralast NP® & Glassia™) and CSL Behring (Zemaira®)
Patient Services:
- Specialty-trained pharmacists and nurses to provide proper
- Alpha-1 patient education and care 24-hour access to clinical support for patients, their family members, and caregivers
- A team of reimbursement specialists to help patients with insurance and claims.
Diplomat Specialty Infusion Group (BioRx)
Telephone: (866) 442-4679
Preferred provider for: Takeda (Aralast NP® & Glassia™) and CSL Behring (Zemaira®)
Coram/CVS Specialty Infusions Services
Telephone: (800) 267-2642 or (866) 899-1661
Preferred provider for: Takeda (Aralast NP® & Glassia™) and CSL Behring (Zemaira®)
Patient Services:
- Specialty-trained pharmacists and nurses to provide proper
- Alpha-1 patient education and care 24-hour access to clinical support for patients, their family members, and caregivers
- A team of reimbursement specialists to help patients with insurance and claims.
As access to care issues are identified, we can take action and engage our grassroots advocacy network. If you are an Alpha patient and your physician has denied your augmentation therapy prescription or if your insurance company will no longer provide coverage for your augmentation therapy, please report it here or contact Cathey Henderson at (877) 346-3212, Director of Community Programs, or by email at chenderson@alpha1.org.
